Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • ACQUIRED HYPOGONADOTROPIC HYPOGONADISM (AHH) IN THALASSAEMIA MAJOR PATIENTS: AN UNDERDIAGNOSED CONDITION?

    Vincenzo De Sanctis
    e2016001
    2016-01-01
    https://doi.org/10.4084/mjhid.2016.001
    5195
    PDF: 1310
    HTML: 3589
  • THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.

    Sagir Gumel Ahmed
    e2011028
    2011-07-08
    https://doi.org/10.4084/mjhid.2011.028
    5189
    PDF: 1337
    HTML: 2755
    Cover letter: 200
  • Acute Hemolytic Anemia Following Rasburicase in a Very Late Post-Transplant Relapse of Acute Myeloid Leukemia

    Gianluca Cavallaro, Federico Lussana, Marco Frigeni, Maria Caterina Micò, Alessandra Algarotti, Anna Grassi, Orietta Spinelli, Chiara Pavoni, Elena Oldani, Alessandro Rambaldi
    e2026003
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.003
    613
    PDF: 503
    Html: 105
  • LIVER IRON CONTENT IN INDIVIDUALS WITH LIVER IRON CONTENT IN INDIVIDUALS WITH Β-THALASSEMIA TRAIT AND HYPERFERRITINEMIA: ROLE OF METABOLIC ALTERATIONS, HFE GENOTYPES, AND CIRRHOSIS.: ROLE OF METABOLIC ALTERATIONS, HFE GENOTYPES, AND CIRRHOSIS. Β-THALASSEMIA TRAIT AND HYPERFERRITINEMIA

    Alberto Piperno
    e2026051
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.051
    134
    PDF: 69
    Suppl. Files: 12
    HTML: 1
  • CURING HEMOGLOBINOPATHIES: CHALLENGES AND ADVANCES OF CONVENTIONAL AND NEW GENE THERAPY APPROACHES.

    Irene Motta, Valentina Ghiaccio, Andrea Cosentino, Laura Breda
    e2019067
    2019-10-30
    https://doi.org/10.4084/mjhid.2019.067
    2902
    PDF: 1859
    HTML: 766
  • MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY

    Emanuele Angelucci, Silvana Anna Maria Urru, Federica Pilo, Alberto Piperno
    e2017021
    2017-03-01
    https://doi.org/10.4084/mjhid.2017.021
    3407
    PDF: 1298
    HTML: 1908
    Fig.1: 206
    Fig. 2: 216
  • SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM

    Zohreh Rahimi, Abbas Parsian
    e2011024
    2011-05-23
    https://doi.org/10.4084/mjhid.2011.024
    2277
    PDF: 903
    HTML: 2099
  • Severe acute axonal neuropathy following treatment with arsenic trioxide for acute promyelocytic leukemia: a case report

    Marcus Kuhn, Mithia Nabergoj, Kety Sammartin, Fabrizio Vianello
    e2016023
    2016-05-01
    https://doi.org/10.4084/mjhid.2016.023
    4092
    PDF: 1011
    HTML: 1566
  • FASTING PLASMA GLUCOSE LEVELS WITHIN THE HIGH NORMAL RANGE ARE ASSOCIATED WITH A SIGNIFICANTLY INCREASED RISK OF FUTURE DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β THALASSEMIA: A DECADE-LONG MULTICENTER RETROSPECTIVE ANALYSIS Higher normal fasting plasma glucose and glucose dysregulation in β- thalassemia

    Vincenzo De Sanctis, Forough Saki, Mehran Karimi, Mohammad Faranoush, Ihab Elhakim, Ashraf T Soliman, Shahina Daar, Ploutarchos Tzoulis
    e2025072
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.072
    657
    PDF: 253
    Html: 33
  • TRANSFUSION PRACTICE, POST-TRANSFUSION COMPLICATIONS AND RISK FACTORS IN SICKLE CELL DISEASE IN SENEGAL, WEST AFRICA.

    Moussa Seck, Alioune Badara Senghor, Mossane Loum, Sokhna Aissatou Touré, Blaise Félix Faye, Alioune Badara Diallo, Mohamed Keita, Elimane Seydi Bousso, Sérigne Mourtalla Guèye, Macoura Gadji, Abibatou Sall, Awa Oumar Touré, Saliou Diop
    e2022004
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.004
    1868
    PDF: 1053
    HTML: 390
  • DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE

    Ibrahim C. Haznedaroglu
    e2015014
    2015-12-02
    https://doi.org/10.4084/mjhid.2015.014
    277694
    PDF: 1810
    HTML: 3875
  • SICKLE CELL DISEASE AND PREGNANCY

    Dipty Jain, Pooja Lodha, Roshan Colah, Prachi Atmapoojya, Prachi Atmapoojya
    e2019040
    2019-06-24
    https://doi.org/10.4084/mjhid.2019.040
    6092
    PDF: 3732
    HTML: 446
  • Bortezomib a safety treatment for patients with Multiple Myeloma and Cystic Fibrosis

    Fabiana Gentilini, Anna Levi, Vincenzo Federico, Eleonora Russo, Robin Foà, Maria Teresa Petrucci
    e2012035
    2012-05-07
    https://doi.org/10.4084/mjhid.2012.035
    1579
    PDF: 757
    HTML: 651
  • PATIENTS WITH HAEMOGLOBINOPATHIES AND CHRONIC HEPATITIS C: A REALLY DIFFICULT TO TREAT POPULATION IN 2016?

    Kalliopi Zachou, Pinelopi Arvaniti, Nikolaos K. Gatselis, Kalliopi Azariadis, Georgia Papadamou, Eirini Rigopoulou, George N. Dalekos
    e2017003
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.003
    2953
    PDF: 986
    HTML: 2066
    Cover letter: 184
  • ASSOCİATİON BETWEEN IRON OVERLOAD AND GLUCOSE METABOLİSM İN CHİLDREN AND YOUTH WİTH TRANSFUSİON-DEPENDENT BETA THALASSEMİA: THE ROLE OF CHELATİON THERAPY

    Deniz Guven, Dr. İncefidan, Dr. Kazanci, Dr. Ozlem Kara
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.017
    672
    PDF: 562
    HTML: 72
  • PREVALENCE OF HEPATITIS C AMONG EGYPTIAN CHILDREN WITH SICKLE CELL DISEASE AND THE ROLE OF IL28B GENE POLYMORPHISMS IN SPONTANEOUS VIRAL CLEARANCE

    Somaia Mohammed Mousa, Mona Kamal El-Ghamrawy, Heba Gouda, Mervat Khorshied, Dina Ahmed, Hala Shiba
    e2016007
    2016-01-01
    https://doi.org/10.4084/mjhid.2016.007
    3842
    PDF: 806
    HTML: 2465
  • THALASSAEMIA AND ABERRATIONS OF GROWTH AND PUBERTY

    Andreas Kyriakou, Nicos Skordis
    e2009003
    2009-07-28
    1156
    PDF: 467
    HTML: 3221
  • FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator

    Claudio Ucciferri, Francesca Chiappini, Jacopo Vecchiet, Katia Falasca
    e2025057
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.057
    2605
    PDF: 966
    HTML: 577
  • The Splenectomy Paradox in Thalassemia: Reduced Transfusion Requirements vs. Accelerated Hepatic Fibrogenesis

    Padmapani Padeniya, Dileepa Ediriweera, Madunil Niriella, Arjuna De Silva, Dulani Kottahachchi, Anuja Premawardhena
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.023
    566
    PDF: 438
    HTML: 90
  • A A RETROSPECTIVE LONG-TERM STUDY ON AGE AT MENARCHE AND MENSTRUAL CHARACTERISTICS IN 85 YOUNG WOMEN WITH TRANSFUSION-DEPENDENT Β-THALASSEMIA (TDT) BORN BETWEEN 1965 AND 1995 Long-Term Study on Age at Menarche and Menstrual Characteristics in patients with TDT

    Vincenzo De Sanctis, Salvatore Di Maio
    e2021040
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.040
    1541
    PDF: 508
    HTML: 181
  • TRANSIENT ELASTOGRAPHY (TE) IS A USEFUL TOOL FOR ASSESSING THE RESPONSE OF LIVER IRON CHELATION IN SICKLE CELL DISEASE PATIENTS

    SOPHIA DELICOU
    e2018049
    2018-09-01
    https://doi.org/10.4084/mjhid.2018.049
    1578
    PDF: 831
    HTML: 195
  • CHARACTERISTICS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA IN MULTI-TRANSFUSED PATIENTS WITH THALASSEMIA MAJOR. EXPERIENCE OF A SINGLE TERTIARY CENTER.

    Nikolaos Papadopoulos, Dimitrios Kountouras, Katerina Malagari, Maria Tampaki, Maria Theochari, John Koskinas
    e2020013
    2020-02-26
    https://doi.org/10.4084/mjhid.2020.013
    1755
    PDF: 963
    HTML: 224
  • CAN WE PREDICT INCIPIENT DIABETES MELLITUS IN PATIENTS WITH TRANSFUSION DEPENDENT β-THALASSEMIA (β-TDT) REFERRED WITH A HISTORY OF PREDIABETES? Risk factors for incipient diabetes in thalassemia

    Vincenzo De Sanctis, Ashraf Soliman, Shahina Daar, Ploutarchos Tzoulis, Christos Kattamis
    e2024005
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.005
    1087
    PDF: 1353
    HTML: 112
51 - 73 of 73 items << < 1 2 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.